Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana | Zendy

George Armah | Zendy; Kimberly Pringle | Zendy; Christabel EnweronuLaryea | Zendy; Daniel Ansong | Zendy; Jason M. Mwenda | Zendy; Stanley Diamenu | Zendy; Clement T. Narh | Zendy; Bélinda Lartey | Zendy; Fred Binka | Zendy; Scott Grytdal | Zendy; Manish M. Patel | Zendy; Umesh D. Parashar | Zendy; Ben Lopman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

Author(s) -

George Armah,

Kimberly Pringle,

Christabel EnweronuLaryea,

Daniel Ansong,

Jason M. Mwenda,

Stanley Diamenu,

Clement T. Narh,

Bélinda Lartey,

Fred Binka,

Scott Grytdal,

Manish M. Patel,

Umesh D. Parashar,

Ben Lopman

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw014

Subject(s) - rotavirus , medicine , rotavirus vaccine , diarrhea , confidence interval , vaccination , odds ratio , confounding , pediatrics , immunization , logistic regression , vaccine efficacy , demography , virology , immunology , immune system , sociology

Ghana was among the first African nations to introduce monovalent rotavirus vaccine (RV1) into its childhood immunization schedule in April 2012. We aimed to assess the impact of vaccine introduction on rotavirus and acute gastroenteritis (AGE) hospitalizations and to estimate vaccine effectiveness (VE).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research